Figure 2.

Acetylshikonin induced morphological changes of tumor cells (×200). (A) A549 control; (B) A549 treated with 25.6 μg/ml acetylshikonin; (C) Bel-7402 control; (D) Bel-7402 treated with 25.6 μg/ml acetylshikonin; (E) MCF-7 control; (F) MCF-7 treated with 25.6 μg/ml acetylshikonin; (G) LLC control; (H) LLC treated with 25.6 μg/ml acetylshikonin.